Lactobacillus reuteri DSM 17938 effectively reduces the duration of acute diarrhoea in hospitalised children

Aim Guidelines consider certain probiotics useful in the management of acute gastroenteritis. This study evaluated the use of Lactobacillus (L) reuteri DSM 17938. Methods A multicentre, randomised, single‐blind clinical trial was performed in hospitalised children with acute gastroenteritis lasting 12–72 h. Children received conventional therapy with, or without, 1 × 10 8 CFU of L. reuteri DSM 17938 for 5 days. The primary endpoint was the...